Status:

COMPLETED

A New Approach for Catheter Ablation of Atrial Fibrillation

Lead Sponsor:

The Second Affiliated Hospital of Kunming Medical University

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18-80 years

Brief Summary

This is a retrospective cohort study of radiofrequency ablation for the treatment atrial fibrillation(AF). Based on the electrophysiological phenomena found in these cases, the investigators propose a...

Detailed Description

The investigators propose a new electrophysiological mechanism for AF: the superposition hypothesis. The investigators tested this hypothesis by conducting the retrospective cohort study to determine ...

Eligibility Criteria

Inclusion

  • patients with underwent the first catheter ablation for symptomatic AF

Exclusion

  • patients with more than one missing follow-up would be excluded

Key Trial Info

Start Date :

January 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 15 2022

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT05989321

Start Date

January 1 2021

End Date

July 15 2022

Last Update

August 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Second Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, China, 650000

A New Approach for Catheter Ablation of Atrial Fibrillation | DecenTrialz